Table 4. Effectiveness of montelukast compared to placebo in children with atopic dermatitis.
Changes after taking Montelukast (Mean±SD) |
Changes after taking Placebo drug (Mean±SD) |
P value | |
---|---|---|---|
SCORAD index | -3.0±11.2 | -5.7±11.3 | 0.43 |
Urine LTE4 (pg/mL) | -65.9±556.2 | 87.7±618.3 | 0.26 |
Urine EDN (ng/mL) | 37.0±1,008.6 | -1,95.8±916.7 | 0.10 |
SCORAD, SCORing Atopic Dermatitis; LTE4, leukotriene E4; EDN, eosinophil-derived neurotoxin.